Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
BMO Capital analyst Sean Dodge initiates coverage on LifeStance Health Gr (NASDAQ:LFST) with a Outperform rating and announc...
UBS analyst Kevin Caliendo maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $9 to $10.
LifeStance Health Gr (NASDAQ:LFST) sees Q4 sales of $368.000 million-$388.000 million vs $379.839 million analyst estimate.
LifeStance Health Gr (NASDAQ:LFST) lowers FY2025 sales outlook from $1.400 billion-$1.440 billion to $1.140 billion-$1.430 bill...
LifeStance Health Gr (NASDAQ:LFST) reported quarterly earnings of $0.00 per share which beat the analyst consensus estimate of ...
UBS analyst Kevin Caliendo maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $8.5 to $9.
